What changed in SINOVAC BIOTECH LTD's 2023 10-K compared to 2022?

Across the narrative sections we track, SINOVAC BIOTECH LTD (SVA) added 0 paragraphs, removed 0, and edited 0 between the 2022 and 2023 10-K filings. The biggest movers are .

Where does this SVA 10-K diff come from?

The source filings are SINOVAC BIOTECH LTD's official 2022 and 2023 Form 20-F annual reports from SEC EDGAR. 10q10k.net parses each filing, aligns paragraphs by section (Item 1, 1A, 1C, 2, 3, 7, 7A), and highlights every added, removed and edited sentence side-by-side.

SINOVAC BIOTECH LTDSVA決算レポート

Nasdaq · ヘルスケア · 医薬製剤

Sinovac Biotech Ltd. is a Chinese biopharmaceutical company based in Haidian District, Beijing that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight. The company has faced bribery probes in China. Its COVID-19 vaccine was the target of a covert disinformation campaign by the US government and a ...

What changed in SINOVAC BIOTECH LTD's 20-F — 2022 vs 2023

No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.